This compound is a nucleoside phosphoramidite designed for automated oligonucleotide synthesis. It features multiple protective groups, including a dimethoxytrityl (DMT) group and a tert-butyldimethylsilyl (TBDMS) group, along with a cyanoethyl phosphoramidite moiety for efficient coupling.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 149559-87-5
(2R,4S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1H-purin-9(6H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
pharmaceutical intermediate
DMF-dG Phosphoramidite
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[(1S)-1-[bis(4-methoxyphenyl)-phenyl-methoxy]ethyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-3-methoxy-tetrahydrofuran-2-yl]purin-6-yl]benzamide
research compound
1H-Imidazole-4-acetamide, N-hydroxy-1-nitroso-
research compound
MOG (35-55)
research compound
((2R,3R,4R,5R)-3-(benzoyloxy)-4-chloro-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methyltetrahydrofuran-2-yl)methyl benzoate
research compound
9,10-diphenylanthracene
research compound
N'-[9-[5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide
RQXRLANMGPTUJP-UHFFFAOYSA-N
CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=NC3=C2N=C(NC3=O)N=CN(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC
—